Detection of integration status of human papillomavirus 16 in cervical precancerous lesions

National Medical Journal of China

Volumn 85, Issue 6, 2005, Pages 400-404

  Chen, Qing Yun ^a   Bian, Mei Lu ^b   Chen, Zhi Hua ^b   Liu, Jun ^b  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b NONE

Author keywords

Cervix neoplasms; Papillomavirus, human; Polymerase chain reaction; Virus integration

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CANCER SCREENING; CONDYLOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; ELECTROPHORESIS; EPISOME; FEMALE; GENE AMPLIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 14844290905     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lang JH. To receive the global challenge and opportunity for preventing cervical cancer. Chin J Obstet Gynecol, 2002, 37: 129-131.
2. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003,16: 1-17.
3. Liu JH, Huang X, Liao GW, et al. Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients. Natl Med J China, 2003, 83: 748-752.
4. Huang S, Afonina I, Miller BA, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 1997, 70: 408-411.
5. Zou C, Vlastos AT, Yang L, et al. Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines. Gynecol Oncol, 2002, 85: 266-273.
6. de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol, 1995, 76: 1057-1062.
7. Hirai Y, Kawamata Y, Takeshima N, et al. Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cellcarcinoma of the uterine cervix. Int J Oncol,2004,24:977-986.
8. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5 + /6( + )-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 1997, 35: 791-795.
9. Yoshinouchi M, Hongo A, Nakamura K, et al. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol, 1999, 37: 3514-3517.
10. Lukaszuk K, Liss J, Wozniak I, et al. Human Papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol, 2003, 41: 608-612.
11. Badaracco G, Venuti A, Sedati A, et al. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol, 2002, 67: 574-582.
12. Vassilakos P, Petignat P, Boulvain M, et al. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer, 2002, 86: 382-388.
13. Hong IS, Marshalleck J, William RH, et al. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of resident samples. A study of 608 cases. Acta Cytol, 2002, 46: 828-834.
14. Abulafia O. Pezzullo JC, Sherer DM. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol, 2003, 90: 137-144.
15. Klinkhamer PJ, Meerding WJ, Rosier PF, et al. Liquid-based cervical cytology. Cancer, 2003, 99: 263-271.
16. Negri G, Menia E, Egarter-Vigl E, et al. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears. Cancer, 2003, 99: 342-345.
17. Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 2001, 82: 238-246.
18. Gallo G, Bibbo M, Bagella L, et al. Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol, 2003, 56: 532-536.
19. Thorland EC, Myers SL, Persing DH, et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res, 2000, 60: 5916-5921.
20. Klimov E, Vinokourova S, Moisjak E, et al. Human papilloma viruses and cervical tumors: mapping of integration sites and analysis of adjacent cellular sequences. BMC Cancer, 2002, 2: 24.
21. Schiller CL, Nickolov AG, Kaul KL, et al. High-risk human papillomavirus detection: a split-sample comparison of hybrid capture and chromogenic in situ hybridization. Am J Clin Pathol, 2004, 121: 537-545.
22. Pan QJ, Li L, Qiao YL, et al. Comparative study on liquid-based cytology for cervical carcinoma screening in a high risk area of China. Chin J Oncol, 2001, 23: 309-312.